Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. From Wikipedia
Takeda targets a March filing after trials showed longer wakefulness with large reductions in cataplexy.
